Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJPS (4) BJID (1) Autor Ali,Zahid (1) Belém,Lindomar de Farias (1) Crespo,Déborah (1) Ferré,Felipe (1) Haq,Inamul (1) Ismail,Mohammad (1) Khan,Fahadullah (1) Khan,Qasim (1) Malaquias,Dalila Pinto (1) Melo,Daniela Oliveira de (1) Nascimento,Yone de Almeida (1) Noor,Sidra (1) Pinheiro,Marcos Luciano Pimenta (1) Pinto,Mauro Cunha Xavier (1) Ribeiro,Eliane (1) Santos,Rômulo Moreira dos (1) Sette,Ivana Maria Fechine (1) Storpirtis,Sílvia (1) Teixeira,Rosângela (1) Mais... Palavra-chave Drug interactions (5) Adverse events (1) Beers criteria (1) Clinical Pharmacy (1) Drug prescriptions. (1) Drugs/adverse reactions (1) Elderly patients/drugs use (1) Elderly/inappropriate use of medicines (1) Health Services/elderly patients (1) Heart diseases (1) Hepatitis C (1) Internal Medicine/hospitals (1) Left ventricular failure (1) Medicines/inappropriate use (1) Patients safety (1) Pharmacoepidemiology (1) Polypharmacy (1) Potential drug-drug interactions (1) Protease inhibitors (1) Rational drug use (1) Mais... Tipo do documento Info:eu-repo/semantics/article (5) Ano 2020 (1) 2016 (1) 2013 (2) 2011 (1) País Brazil (5) Idioma Inglês (5)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 5 Primeira ... 1 ... Última Safety aspects of protease inhibitors for chronic hepatitis C: adverse events and drug-to-drug interactions BJID Teixeira,Rosângela; Nascimento,Yone de Almeida; Crespo,Déborah. The standard of care therapy of chronic hepatitis C with the combination of pegylated interferon and ribavirin for 24 or 48 weeks was a remarkable accomplishment of the past decade. However, sustained virological responses rates of about 80% (genotypes 2-3) and 50% (geno 3 type 1) were not satisfactory especially for patients infected with genotype 1. Important advances in the biology of HCV have made possible the development of the direct-acting antiviral agents boceprevir and telaprevir with substantial increase in the rates of sustained virological response with shorter duration of therapy for a large number of patients. However, the complexity of triple therapy is higher and several new side effects are expected suggesting greater expertise in the... Tipo: Info:eu-repo/semantics/article Palavras-chave: Hepatitis C; Protease inhibitors; Adverse events; Drug interactions. Ano: 2013 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000200013 Drug use by elderly inpatients of a philanthropic hospital BJPS Santos,Rômulo Moreira dos; Sette,Ivana Maria Fechine; Belém,Lindomar de Farias. The high incidence of chronic diseases in the elderly leads to increased intermittent drug therapies. The presence of concomitant diseases and prescriptions made out by various health professionals facilitate the practice of polypharmacy, the emergence of iatrogenic diseases, and therapeutic regimens that are inconvenient for patients. The present study was carried out among elderly patients hospitalized at the Hospital Care Foundation of Paraiba, Campina Grande, with the objectives of studying the consumption of drugs by these patients, noting the possible adverse drug reactions (ADR), drug interactions and the presence of high-risk drugs prescribed to this age group. The study had a descriptive and cross-sectional quantitative design and involved a... Tipo: Info:eu-repo/semantics/article Palavras-chave: Elderly patients/drugs use; Polypharmacy; Drugs/adverse reactions; Drug interactions. Ano: 2011 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502011000200021 Potentially inappropriate medication use among institutionalized elderly individuals in southeastern Brazil BJPS Pinto,Mauro Cunha Xavier; Malaquias,Dalila Pinto; Ferré,Felipe; Pinheiro,Marcos Luciano Pimenta. In recent decades, the elderly population in Brazil has grown rapidly, as has concern for the health of this population. Institutionalization in nursing homes has appeared as an alternative form of health care for frail elderly that live alone. The present study evaluated the pharmacotherapy and inappropriate drug prescriptions for institutionalized elderly patients living in long-term institutions in southeastern Brazil. This research was conducted at five institutions with a total sample of 151 individuals aged at least 60 years. Databases were used to identify drug interactions, defined daily dose and inappropriate prescriptions. The prevalence of drug intake among the elderly was 95.36%, and there were an average of 3.31 ± 1.80 drug prescriptions per... Tipo: Info:eu-repo/semantics/article Palavras-chave: Pharmacoepidemiology; Drug interactions; Beers criteria; Elderly/inappropriate use of medicines; Medicines/inappropriate use. Ano: 2013 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000400010 Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients? BJPS Melo,Daniela Oliveira de; Storpirtis,Sílvia; Ribeiro,Eliane. ABSTRACT The purpose of the work was to assess the incidence of potential drug interactions (pDDI), major pDDI, and the use of potentially inappropriate medication (PIM) at hospital admission, during hospitalization, and at discharge to evaluate whether hospital admission provides an opportunity for improving pharmacotherapy in elderly patients at a University hospital that has a clinical pharmacist. A prospective cohort study was carried out using data from the medical records of patients admitted to an internal medicine ward. All admissions and prescriptions were monitored between March and August 2006. Micromedex(r) DrugReax(r) and Beers Criteria 2015 were used to identify pDDI, major pDDI, and PIMs, respectively. A comparison of admission and discharge... Tipo: Info:eu-repo/semantics/article Palavras-chave: Health Services/elderly patients; Internal Medicine/hospitals; Clinical Pharmacy; Drug interactions; Drug prescriptions.. Ano: 2016 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502016000300391 Prevalence, predictors and outcomes of potential drug-drug interactions in left ventricular failure: considerable factors for quality use of medicines BJPS Haq,Inamul; Ismail,Mohammad; Khan,Fahadullah; Khan,Qasim; Ali,Zahid; Noor,Sidra. Hospitalized patients with left ventricular failure (LVF) are at high risk for potential drug-drug interactions (pDDIs) and its related adverse effects owing to multiple risk factors such as old age, comorbidities and polypharmacy. This cross-sectional study conducted in two tertiary care hospitals aim to identify frequency, levels and predictors of pDDIs in LVF patients. Data about patients’ demographic, hospital stay, medication therapy, sign/symptoms and laboratory test results were collected for 385 patients with LVF. Micromedex Drug-Reax® was used to screen patients’ medication profiles for pDDIs. Overall prevalence and severity-wise prevalence of pDDIs were identified. Chi-square test was performed for comparative analysis of various variables.... Tipo: Info:eu-repo/semantics/article Palavras-chave: Left ventricular failure; Heart diseases; Potential drug-drug interactions; Drug interactions; Patients safety; Rational drug use. Ano: 2020 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100589 Registros recuperados: 5 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco